ARCHIVES

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

COG Begins Phase III Trial To Prevent Hearing Loss

May 30, 2008

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

ACS Funds $54 Million in Grants

June 28, 2002

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

High-Starch Diet May Raise Risk Of Pancreatic Cancer

October 25, 2002

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014